Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...

The popularity of weight loss drugs has soared during the past few years as new injectable medications have appeared as an effective and safe solution to obesity. But while these drugs may be one of ...

Steady newsflow concerning potential rivals to Novo Nordisk’s weight-loss and diabetes drugs Ozempic and Wegovy has dented the investment case, said Soren Lontoft Hansen, senior analyst at ...

WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...